MCAST COVID-19

Information Page

The health and safety of our community is our top priority. We know that many people are understandably concerned about the current pandemic situation. MCAST is taking increased health and safety measures to address these concerns while ensuring that learning can continue. As the situation continues to develop, please stay updated by visiting mcast.edu.mt/covid19 for the latest information. You can also visit the circulars section for all the official messages sent to staff and students.

 

Distancing

  • Communicable disease threats report, 26 July−1 August 2025, week 31
    by ECDC on August 1, 2025 at 12:41 pm

    This issue of the CDTR covers the period 26 July−1 August 2025 and includes updates on dengue, mpox, chikungunya virus disease, Crimean-Congo haemorrhagic fever, West Nile Virus, cholera, Botulism, respiratory viruses, avian influenza A(H5N1), SARS-CoV-2, mass gathering monitoring for the Jubilee of 2025 in Italy and mass gathering monitoring for UEFA Women's EURO 2025.

  • Communicable disease threats report, 19−25 July 2025, week 30
    by ECDC on July 25, 2025 at 4:07 pm

    This issue of the CDTR covers the period 19−25 July 2025 and includes updates on respiratory viruses, avian influenza A(H9N2), avian influenza A(H5N1), cholera, Oropouche, mass gathering monitoring for the Jubilee of 2025 in Italy, mass gathering monitoring for UEFA Women's EURO 2025, Crimean-Congo haemorrhagic fever, West Nile Virus, dengue and chikungunya virus disease.

  • The European Respiratory Virus Surveillance Summary (ERVISS)
    by ECDC on July 11, 2025 at 12:09 pm

    This interactive dashboard provides a weekly integrated epidemiological summary for influenza, RSV and SARS-CoV-2.

  • Communicable disease threats report, 28 June - 4 July 2025, week 27
    by ECDC on July 4, 2025 at 4:10 pm

    This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 28 June - 4 July 2025 and includes updates on influenza A(H5N1), Middle Eastern Respiratory Syndrome (MERS), SARS-CoV-2, updates on respiratory virus epidemiology in the EU/EEA, poliomyelitis, Crimean-Congo haemorrhagic fever, West Nile virus infection, and chikungunya.

  • Reporting protocol for zoonotic influenza virus
    by ECDC on June 30, 2025 at 7:06 am

    This reporting protocol describes data collection for human cases of zoonotic influenza viruses, with the aim to support assessment of key indicators and trends over time and inform situational risk assessments.

News (English) - World Health Organization Corporate news releases, statements, and notes for media issued by the World Health Organization.

  • On World Breastfeeding Week, countries urged to invest in health systems and support breastfeeding mothers
    on August 5, 2025 at 8:15 am

    Strengthening health systems to support breastfeeding is not just a health imperative, it is a moral and economic imperative. WHO and UNICEF remain committed to supporting countries to build resilient health systems that leave no mother or child behind.

  • Paying tribute to David Nabarro
    on July 30, 2025 at 8:56 am

    Tribute to Dr David Nabarro

  • IPC Gaza Strip Food Insecurity and Malnutrition Alert
    on July 29, 2025 at 9:05 am

    The Integrated Food Security Phase Classification (IPC), of which WHO is a member, today issued a Food Insecurity and Malnutrition Alert for the Gaza Strip. The details are as noted below. Key highlights The Integrated Food Security Phase Classification (IPC) has issued a stark warning today that the worst-case scenario of Famine is now unfolding in the Gaza Strip. Amid relentless conflict, mass displacement, severely restricted humanitarian access, and the collapse of essential services, including healthcare, the crisis has reached an alarming and deadly turning point. Mounting evidence shows that widespread starvation, malnutrition, and disease are driving a rise in hunger-related deaths. Latest data indicates that Famine thresholds have been reached for food consumption in most of the Gaza Strip and for acute malnutrition in Gaza City.Recommended actions End hostilitiesEnsure humanitarian accessProtect civilians, aid workers, and civilian infrastructureRestore life-saving and multi-sectoral humanitarian assistance safely and with dignityRestore the flow of commercial goods and local production capacities.About the IPCThe Integrated Food Security Phase Classification (IPC) is an innovative multi-partner initiative for improving food security and nutrition analysis and decision-making. By using the IPC classification and analytical approach, governments, UN agencies, nongovernmental organizations, civil society and other relevant actors work together to determine the severity and magnitude of acute and chronic food insecurity, and acute malnutrition situations in a country, according to internationally recognized scientific standards.The main goal of the IPC is to provide decision-makers with a rigorous, evidence- and consensus-based analysis of food insecurity and acute malnutrition situations, to inform emergency responses as well as medium- and long-term policy and programming.

  • Global hunger declines, but rises in Africa and western Asia: UN report
    on July 28, 2025 at 3:21 pm

    An estimated 8.2 percent of the global population, or about 673 million people, experienced hunger in 2024, according to the latest State of Food Security and Nutrition in the World (SOFI) report published today by five United Nations specialized agencies.

  • WHO urges action on hepatitis, announcing hepatitis D as carcinogenic
    on July 28, 2025 at 1:08 pm

    As we mark World Hepatitis Day, WHO calls on governments and partners to urgently accelerate efforts to eliminate viral hepatitis as a public health threat and reduce liver cancer deaths."Every 30 seconds, someone dies from a hepatitis-related severe liver disease or liver cancer. Yet we have the tools to stop hepatitis,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. Viral hepatitis – types A, B, C, D, and E – are major causes of acute liver infection. Among these only hepatitis B, C, and D can lead to chronic infections that significantly increase the risk of cirrhosis, liver failure, or liver cancer. Yet most people with hepatitis don’t know they’re infected. Types B, C, and D affect over 300 million people globally and cause more than 1.3 million deaths each year, mainly from liver cirrhosis and cancer.Hepatitis D now classified as carcinogenicThe International Agency for Research on Cancer (IARC) recently classified hepatitis D as carcinogenic to humans, just like hepatitis B and C. Hepatitis D, which only affects individuals infected with the hepatitis B, is associated with a two- to six-fold higher risk of liver cancer compared to hepatitis B alone. This reclassification marks a critical step in global efforts to raise awareness, improve screening, and expand access to new treatments for hepatitis D.“WHO has published guidelines on testing and diagnosis of Hepatitis B and D in 2024, and is actively following the clinical outcomes from innovative treatments for hepatitis D,” said Dr Meg Doherty, incoming Director of Science for Health at WHO.Treatment with oral medicine can cure hepatitis C within 2 to 3 months and effectively suppress hepatitis B with life-long therapy. Treatment options for hepatitis D are evolving. However, the full benefit of reducing liver cirrhosis and cancer deaths can only be realized through urgent action to scale up and integrate hepatitis services – including vaccination, testing, harm reduction, and treatment – into national health systems.Latest data and progressEncouragingly, the majority of low- and middle-income countries (LMICs) have strategic plans on hepatitis in place and progress in national hepatitis responses is increasing:in 2025, the number of countries reporting national hepatitis action plans increased from 59 to 123; as of 2025, 129 countries have adopted policies for hepatitis B testing among pregnant women, up from 106 reported in 2024; and147 countries have introduced the hepatitis B birth dose vaccination, an increase from 138 in 2022.However, critical gaps remain in service coverage and outcomes, as stated in the 2024 Global Hepatitis Report:testing and treatment coverage remain critically low; only 13% of people with hepatitis B and 36% with hepatitis C had been diagnosed by 2022;treatment rates were even lower – 3% for hepatitis B and 20% for hepatitis C – well below the 2025 targets of 60% diagnosed and 50% treated; andintegration of hepatitis services remains uneven: 80 countries have incorporated hepatitis services into primary health care; 128 into HIV programmes and just 27 have integrated hepatitis C services into harm reduction centres.The next challenge will be to scale up the implementation of prevention, testing and treatment coverage. Achieving WHO’s 2030 targets could save 2.8 million lives and prevent 9.8 million new infections. With declining donor support, countries must prioritize domestic investment, integrated services, better data, affordable medicines, and ending stigma.Forging new partnershipsTo mark World Hepatitis Day, WHO is partnering with Rotary International and the World Hepatitis Alliance to strengthen global and local advocacy. This year’s campaign “Hepatitis: Let’s break it down” demands action to confront the rising toll of liver cancer linked to chronic hepatitis infections. It also calls for decisive steps to dismantle persistent barriers – from stigma to funding gaps – that continue to slow progress in prevention, testing, and treatment.Through a joint webinar and coordinated outreach, the partnership underscores the vital role of civil society and community leadership, alongside governments, in sustaining momentum and accelerating progress toward hepatitis elimination.